Pensioenfonds Rail & OV Buys New Holdings in Intuitive Surgical, Inc. $ISRG

Pensioenfonds Rail & OV purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) in the third quarter, HoldingsChannel.com reports. The fund purchased 12,358 shares of the medical equipment provider’s stock, valued at approximately $5,025,000. Intuitive Surgical comprises 1.3% of Pensioenfonds Rail & OV’s holdings, making the stock its 27th largest position.

A number of other institutional investors and hedge funds also recently made changes to their positions in ISRG. Trillium Asset Management LLC increased its stake in Intuitive Surgical by 78.4% in the third quarter. Trillium Asset Management LLC now owns 50,395 shares of the medical equipment provider’s stock valued at $20,493,000 after acquiring an additional 22,145 shares during the last quarter. Phoenix Financial Ltd. raised its position in Intuitive Surgical by 30.3% during the third quarter. Phoenix Financial Ltd. now owns 12,657 shares of the medical equipment provider’s stock valued at $4,861,000 after purchasing an additional 2,940 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. raised its position in Intuitive Surgical by 10.9% during the third quarter. Migdal Insurance & Financial Holdings Ltd. now owns 347 shares of the medical equipment provider’s stock valued at $141,000 after purchasing an additional 34 shares in the last quarter. Dogwood Wealth Management LLC raised its position in Intuitive Surgical by 178.3% during the third quarter. Dogwood Wealth Management LLC now owns 64 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 41 shares in the last quarter. Finally, Cornerstone Advisory LLC lifted its stake in Intuitive Surgical by 39.2% during the third quarter. Cornerstone Advisory LLC now owns 809 shares of the medical equipment provider’s stock worth $329,000 after purchasing an additional 228 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Gary Guthart sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $457.34, for a total transaction of $4,573,400.00. Following the sale, the director directly owned 1,194,530 shares of the company’s stock, valued at $546,306,350.20. The trade was a 0.83% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Craig Barratt sold 1,150 shares of Intuitive Surgical stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $460.00, for a total transaction of $529,000.00. Following the transaction, the director owned 1,150 shares in the company, valued at approximately $529,000. This trade represents a 50.00% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 39,456 shares of company stock worth $17,769,124 over the last quarter. Insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Up 0.8%

Shares of ISRG stock traded up $3.70 during mid-day trading on Friday, reaching $443.59. 1,604,248 shares of the stock traded hands, compared to its average volume of 2,787,457. The stock’s fifty day simple moving average is $417.59 and its two-hundred day simple moving average is $429.98. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The company has a market cap of $153.77 billion, a price-to-earnings ratio of 53.64, a price-to-earnings-growth ratio of 3.03 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company had revenue of $3.05 billion during the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter in the prior year, the firm posted $2.40 earnings per share. The firm’s revenue was up 21.7% compared to the same quarter last year. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Thursday, October 22nd. KeyCorp reissued an “overweight” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. BTIG Research restated a “buy” rating and set a $454.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Raymond James Financial reaffirmed an “outperform” rating and issued a $480.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Finally, UBS Group reiterated a “buy” rating on shares of Intuitive Surgical in a research report on Tuesday, October 13th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $493.54.

Read Our Latest Stock Analysis on ISRG

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.

Recommended Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.